FineMark National Bank & Trust’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

FineMark National Bank & Trust’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-136	Closed	-$7K	–	1475
2016 Q1	$7K	Buy	136 +128	+1,600%	+$9.45K	﹤0.01%	998
2015 Q4	$1K	Buy	+8	New	+$881	﹤0.01%	1337

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

FineMark National Bank & Trust's ANAC Position: Q2 2016 in Review

FineMark National Bank & Trust sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 136 shares — an estimated $7K sold.

FineMark National Bank & Trust first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $7K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

FineMark National Bank & Trust reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
FineMark National Bank & Trust sold 136 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $7K.
FineMark National Bank & Trust first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
FineMark National Bank & Trust's ANACOR PHARMACEUTICALS INC COM position peaked at $7K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on FineMark National Bank & Trust's 13F filing for Q2 2016, filed 8 Aug 2016.